-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: University of Bergen
Developments in Smart Assistive Technology to Support People With Dementia (Frontiers in Pharmacology)
Summary A recent systematic investigates the use of remote “sensing technology” to assess behavioural and psychological symptoms of dementia (BPSD), and for monitoring people with dementia more generally. The broad categories of technology considered include (i) wearable sensors, (ii) non-wearable … Continue reading →
Posted in Assistive Technology, Commissioning, Community Care, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, International, Management of Condition, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, Systematic Reviews, Telecare, Telehealth, Universal Interest
|
Tagged (Bergen Norway), Assistive Technology (AT), Assistive Technology and Telecare, Assistive Technology in Dementia Care, Assistive Technology Services, AT: Assistive Technology, Behavioural and Psychological Symptoms of Dementia (BPSD), Behavioural Problems, Behavioural Problems in People With Dementia, Benefits of Remote Monitoring, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Centre for Elderly and Nursing Home Medicine: University of Bergen, Continuous Monitoring, Dementia Wandering Prevention Devices, Department of Global Public Health and Primary Care: University of Bergen, Department of Nursing Home Medicine (Bergen Norway), Department of Psychiatry: Harvard Medical School, Digital Innovation, Digital Technology and Innovation, Division of Geriatric Psychiatry: McLean Hospital, Electronic Assistive Technology or Telecare (ATT), Ethical Considerations, Ethical Innovation, Ethical Issues of Dementia Care, Ethics of Assistive Technology, Frontiers in Pharmacology, Hardware and Wearables, Harvard Medical School (Boston), McLean Hospital (Belmont USA), Monitoring and Surveillance, Monitoring Devices, NKS Olaviken Gerontopsychiatric Hospital, Non-Invasive Telemonitoring, Norway, Remote Monitoring, Smart Home Adaptations, Smart Homes, Smart Housing, Smart Sensors, Surveillance Equipment, Sustainable Ethical Innovation, Systematic Reviews and Meta-Analyses, Technology and Innovation, Telehealth (Remote Monitoring), Telemonitoring, United States, University of Bergen, USA, Usability of Assistive Technology, Use and Awareness of Assistive Technology in Community Care, Use and Awareness of Assistive Technology in Dementia Care, Views on Telemonitoring Services, Wandering Prevention Devices, Wearable Devices, Wearable Devices for People With Dementia, Wearable Monitoring Equipment, Wearable Sensors, Wearable Technology, Wearables (Technology)
|
Leave a comment
Questions Raised About Prescribing Painkillers for Dementia Patients (BBC Radio Four / BBC News)
Summary An investigation into the role of big pharma in the international opioid crisis, from BBC Radio 4, touches upon questions about the ethics and suitability of pain management embedded semi-routinely in care for persons with dementia: Full Audio Link … Continue reading →
Posted in Acute Hospitals, BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, NHS, Pain, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged Addressing Problematic Opioid Use in OECD Countries (OECD 2019), Analgesic Misuse, Analgesic Treatments for People With Dementia, Availability of Opioid Painkillers, Avoidable Harm, BBC Radio 4, BBC Radio Four, BBC Radio Four File on 4, BBC Radio Four’s “File on Four” Programme, Behavioural and Psychological Symptoms of Dementia (BPSD), Big Pharma, Centre for Elderly and Nursing Home Medicine: University of Bergen, Department of Global Public Health and Primary Care: University of Bergen, Department of Health and Care (Bergen Norway), Department of Psychiatry: Harvard Medical School, Deprescribing, Distressed Behaviour, Ethical Dilemmas, Ethical Issues of Dementia Care, Evidence Uncertainties, Expert Opinion on Drug Safety (Journal), Fentanyl, Harvard Medical School, Impact of Opioids, McLean Hospital (Belmont USA), McLean Institute for Technology in Psychiatry and Geriatric Psychiatry Outpatient Services: McLean Hospital (Belmont USA), Medicines Optimisation Group: University of East Anglia, Morphine, NIHR CLAHRC East, NIHR CLAHRC Eastern, Norway, Office for Economic Co-operation and Development (OECD), Opioid Addiction, Opioid Analgesics Dependency, Opioid Crisis, Opioid Deprescribing, Opioids, Optimising Prescribing and Deprescribing in Older Adults With Dementia, Over-Medication, Over-Prescribing, Pain Control and Dementia in the Acute Hospital, Pain Management, Pain Prevalence, Pain Relief, Painkillers, Painkillers Don’t Exist (Public Awareness Campaign), Patient Harm, Psychological and Behavioural Distress, Reducing Agitation and Distress, Reducing Avoidable Harm, Strong Opioids: First-Line Maintenance, Strong Opioids: First-Line Oral Opioids, Strong Opioids: First-Line Transdermal Patches, Tackling Over-Medication, Tramadol, Treatment of Pain to Reduce Behavioural Disturbances, University of Bergen, University of East Anglia, University of East Anglia Medicines Optimisation Group, University of Exeter Medical School, Untreated Pain, USA, USA Opioid Epidemic
|
Leave a comment
Healthy Eating: Unhealthy Disagreements About the Causes of Obesity (BBC News / NHS Choices / NOF / PHC / PHE)
Summary An epic battle for hearts and minds appears to be underway, concerning the relative merits of alternative approaches to tackling obesity at the population level through diet and nutritional advice. The National Obesity Forum and the Public Health Collaboration … Continue reading →
Posted in Acute Hospitals, BBC News, Charitable Bodies, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, In the News, Integrated Care, International, National, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Nutrition, Patient Information, Practical Advice, Public Health England, Quick Insights, Royal College of Physicians, UK, Universal Interest
|
Tagged Adiposity, American Journal of Clinical Nutrition, BBC Health News, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Behind the Headlines, Bergen Medical Research Foundation, Calorie-Focused Thinking, Cherry-Picking Studies (Allegation), Dementia Risk Factors, Dementia Risk Reduction, Department of Clinical Medicine: University of Bergen, Department of Heart Disease: Haukeland University Hospital, Dietary Choices, Dietary Factors, Dietetics, Dr Alison Tedstone: Public Health England, Dr Aseem Malhotra: Senior Adviser to the National Obesity Forum, Eat Fat Cut The Carbs (PHC / NOF), Eat More Fat Controversy, Eating and Drinking, Eating Well, Eatwell Guide and Eatwell Plate, Eatwell Guide For Healthy Eating, Eatwell Guide. Public Health England (PHE), Eatwell Plate, Eatwell Plate: External Reference Group Review, Epidemiology, Epidemiology and Statistics, Excess Energy Intake, Haukeland University Hospital, Health Policy, Healthy Ageing, Healthy Behaviours, Healthy Communities, Healthy Eating Dietary Guidelines for United Kingdom, Healthy Eating Guidelines (PHC / NOF), Healthy Eating Guidelines and Weight Loss Advice For the United Kingdom, Healthy Lifestyles, Healthy Living, Healthy Weight, Improving Dietary Habits, Integrated Prevention Approaches, Junk Food, KG Jebsen Centre for Diabetes Research, Life Course Approach, Life-Course Approach to Healthy and Active Ageing, Lifestyle, Lifestyle Intervention Programmes, Lifestyle Risk Factors, Low-Fat High-Carbohydrate (LFHC) Diet, Mainstream Dietary Guidance: Avoidance of Foods Based on Saturated Fat Content, Mainstream Dietary Guidance: Dietary Reference Value of No More Than 35% Total Fat, Mainstream Dietary Guidance: Recommended Quality and Quantity of Carbohydrates, Meltzerfondet, Metabolic Syndrome, Mixed Messages, Modifiable Risk Factors, Myth-Busting, National Advisory Committee on Nutritional Education (USA), National Obesity Forum, Non-Adherence to Systematic Review Methods (Allegation), Nutritional Epidemiology and Public Health, Obesity, Obesity and Diabetes, Obesity Epidemic, Obesity in the UK, Obesity Risk, Obesity Risk Factor, Obesity Statistics, Obesity Time-Bomb, Overlapping Risk Factors, PHC / NOF Advice to Avoid Snacking To Reverse Obesity and Type 2 Diabetes, PHE: Public Health England, Poor Dietary Advice (Allegations Reciprocal), Preventing Excess Weight Gain, Preventing Type 2 Diabetes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prevention of Dementia, Prevention Programmes, Preventive Care, Prof Simon Capewell: Faculty of Public Health, Professor David Haslam: Chairman of National Obesity Forum, Public Awareness, Public Health, Public Health Collaboration (PHC / NOF), Public Health Collaboration (PHC), Public Health Interventions, Real Food Lifestyle, Risk Factors, Royal Society for Public Health, SACN: Scientific Advisory Committee on Nutrition (Successor to COMA), Scientific Advisory Committee on Nutrition (SACN), Staying Healthy for Longer, The Real Food Lifestyle (PHC / NOF), Tolerance of Ambiguity, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, University of Bergen, Very High-Fat Low-Carbohydrate (VHFLC) Diet, Weight Loss Advice For The United Kingdom (PHC / NOF), Western Norway Regional Health Authority, You Cannot Outrun a Bad Diet (Myth of Physical Inactivity and Obesity)
|
Leave a comment
Funding Initiative (JPco-fuND) for International Dementia Research (MRC)
Summary The EU Joint Programme for Neurodegenerative Disease Research (JPND) has announced €35 million (£25.7 million) funding for research into neurodegenerative diseases. Nine of the 21 research projects involved will benefit UK research teams; these will receive MRC funds through … Continue reading →
Posted in Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, National, Parkinson's Disease, Quick Insights, UK
|
Tagged 3DMinBrain, 3DPD, Aarhus University, ADAGE: Alzheimer’s Disease Pathology Within the Ageing Physiology., AIT Austrian Institute of Technology Vienna, Animal and Cell Models, aSynProtec: Alpha-Synuclein Pathology Propagation in Parkinson’s Disease and Quest for Novel Protective Strategies., Australia, BRIDGET: Brain Imaging Cognition Dementia and Next Generation GEnomics: a Transdisciplinary Approach to Search for Risk and Protective Factors of Neurodegenerative Disease., Cambridge, Canada, Cardiff, Cardiff University, Centre National de la Recherche Scientifique Bordeaux, Centre National de la Recherche Scientifique Gif sur Yvette, Charité Universitätsmedizin Berlin, CircProt, CNRS Valbonne, Collaboration, Collaboration: Working Across Boundaries, Collaborative Projects, Collaborative Research, Copenhagen University, Cross-Sector Partnerships, CureALS, DACAPO-AD, Dementia Research, Dementia Risk Factors, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Bonn, Deutsches Zentrum für Neurodegenerative Erkrankungen Tübingen, Dr Rob Buckle: Director of Science Programmes at the Medical Research Council, EADB: A European DNA Bank for Deciphering the Missing Heritability of Alzheimer’s Disease., Edinburgh, EfrAME: Pathway Complexities of Protein Misfolding in Neurodegenerative Diseases: a Novel Approach to Risks Evaluation and Model Development, Environment and Health, EPI-AD: Targeting Epigenetic Dysregulation in the Brainstem in Alzheimer’s Disease., ERA-NET Co-fund, Erasmus MC Rotterdam, Erasmus MC University Medical Center, ESMI: European Spinocerebellar Ataxia Type 3 / Machado-Joseph Disease Initiative., EU Joint Programme in Neurodegenerative Disease (JPND), EU Joint Programme on Neurodegenerative Disease Research (JPND), EU Joint Programme: Neurodegenerative Disease Research (JPND), Europe, European Member States, Faculdade de Ciencias Medicas da Universidade Lisboa, Fondazione IRCCS Istituto Neurologico Carlo Besta Milano, Foundation Carlo Besta Neurological Institute, Funding Alignment of European Member States: Associated Countries: Three Third Countries (Canada Switzerland and Australia), Funding Initiatives, GBA-PARK: GBA1 Mutations in Parkinson Disease: Clinical and Biochemical Prodrome Risk Profile and Pathogenetic Modelling for Therapeutic Intervention., German Center for Neurodegenerative Diseases DZNE Tübingen, Global Challenge of Neurodegenerative Disease, Global Leadership, Global Outlook, H. Lundbeck A/S, Hebrew University of Jerusalem, Heinrich-Heine-University Duesseldorf, Horizon 2020, Hospital Universitari Vall D'Hebron, IGBMC/CNRS/INSERM/Unistra Illkirch, Inserm Lille Hinxton, Inserm U836, Inserm U862, Inserm/UEVE U861 Evry, INSTALZ: Genomic Instability in Alzheimer’s Disease and Related Disorders: a Single-Cell Approach., Institut du Cerveau et de la Moelle Epiniere Paris, Institut Pasteur de Lille, International Collaborations, International Dementia Research, International Partnerships, International Programmes, IRCCS C. Mondino National Neurological Institute, Istituto Nazionale Neurologico Carlo Besta Milan, Joint Transnational Co-Funded Projects in Partnership with European Commission Under ERA-NET Co-fund Scheme, JPco-fuND Initiative, JPcofuND (Funding Programme), JPND Initiative, JPND Research Projects, JPND Research Strategy, JPND Transnational Research, Julius-Maximilians-University of Würzburg, Karolinska Institute Stockholm, Karolinska Institutet, Karolinska Institutet (Stockholm), King’s College, KU Leuven, Laboratory of Molecular Biology (LMB) Neuroscience Division, Lausanne University Hospital (CHUV), Leibniz Institute for Neurobiology, Leuven University, Lifestyle Risk Factors, London, London University College, Longitudinal Cohorts, Lund University, Luxembourg Centre for Systems Biomedicine, MADGIC, Max-Planck-Institute for Molecular Biomedicine Muenster, McGill Genome Center Montréal, Medical Research Council (MRC), Medical Research Council Cambridge, Medical University Graz, Medical University of Greifswald, Misfolded Proteins, ModelPolyQ, NAB3, National Research Council, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Overlapping Risk Factors, Oxford, Oxford Parkinson's Disease Centre, Oxford Parkinson's Disease Centre: University of Oxford, Partnership, Partnership and Collaboration, Partnership Working, Professor Philippe Amouyel: Chair of JPND Management Board and Coordinator of JPco-fuND Initiative, PROP-AD, Protein Misfolding, Radboud University Medical Center Nijmegen, REfrAME, Rheinische-Friedrich-Wilhelms-Universität Bonn, Risk and Protective Factors, Risk Factors, Saarland University, Sanger Institute, Sanger Institute-EBI Single-Cell Genomics Centre, Scuola Internazionale Superiore di Studi Avanzati-SISSA Trieste, Slovak Academy of Sciences (SAS) Bratislava, SNOWBALL, STAD, Stichting VU-VUmc Amsterdam, Swiss Federal Institute of Technology Lausanne, Switzerland, SYNACTION, Technion Haifa, Technische Universität Dresden, The Royal Institute of Technology Stockholm, Tissue Disease and Degeneration, Universidade de Lisboa, Universita' degli studi di Milano, Universitaetsklinikum Bonn, Università degli Studi di Modena e Reggio Emilia Modena, Universite D´Artois, University College London, University College London (UCL), University College of London (UCL), University Hospital Cologne, University Hospital of Bonn, University Medical Center Goetingen, University Medical Center Utrecht, University of Bergen, University of Bonn, University of Coimbra, University of Copenhagen, University of Eastern Finland, University of Eastern Finland Kuopio, University of Edinburgh, University of Exeter Medical School, University of Helsinki, University of Mainz, University of Milan, University of Milano, University of New South Wales, University of Ottawa, University of Oxford, University of Tübingen, University of Tel Aviv, University of the Azores Ponta Delgada, University of Toulouse, University of Tuebingen, University of Würzburg, University of Zurich (UZH), Upsalla University, VU University Medical Center
|
Leave a comment
Pain in Impaired Cognition: EU COST Programme (COST TD1005 Action)
Summary The European Cooperation in the Field of Scientific and Technical Research (COST) offers an inter-governmental framework which sponsors and promotes collaboration between researchers in Europe. One component of this work is the EU-COST initiative entitled “Pain in impaired cognition, … Continue reading →
Posted in Acute Hospitals, Community Care, End of Life Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Models of Dementia Care, Pain, Person-Centred Care, Quick Insights, Systematic Reviews, UK
|
Tagged Academic Centre for Dentistry Amsterdam (ACTA): University of Amsterdam, Assessment of Pain in Elderly Patients With Severe Dementia, Back Pain, Barriers: Poor Pain Management, BMC Neurology, British Medical Bulletin, Centre for Elderly and Nursing Home Medicine: University of Bergen, Chronic Pain, Clinical Interventions in Aging, Collaboration, Collaborative Communication, Collaborative Projects, Collaborative Research, Collaborative Working, COST Action TD1005: Pain Assessment in Patients with Impaired Cognition Especially Dementia, COST TD1005 Action Work Group 1: Psychometrics and Algesimetry (WG1), COST TD1005 Action Work Group 2: Nursing and Care (WG2), COST TD1005 Action Work Group 3: Clinical Evaluation and Epidemiology (WG 3), COST TD1005 Action Work Group 4: Experimental Evaluation (WG 4), COST TD1005 Action Work Group 5: Palliative Care (WG 5), Decoding Pain From Facial Display of Patients With Dementia, Dementia Care in Acute General Hospitals, Dementia Care in Acute Settings, Dementia Care in General Hospitals, Department of Global Public Health and Primary Care: University of Bergen, Department of Oral Function: University of Amsterdam, Department of Public Health and Primary Care Medicine: Leiden University Medical Center, Department of Public Health and Primary Care: Leiden University Medical Center, EU COST Program for COST Action TD1005, EU COST Programme (COST TD1005 Action) Work Group 1 (WG 1): Psychometrics and Algesimetry, EU COST Programme (COST TD1005 Action) Work Group 2 (WG 2): Nursing and Care, EU COST Programme (COST TD1005 Action) Work Group 3 (WG 3): Clinical Evaluation and Epidemiology, EU COST Programme (COST TD1005 Action) Work Group 4 (WG 4): Experimental Evaluation, EU COST Programme (COST TD1005 Action) Work Group 5 (WG 5): Palliative Care, European Cooperation in the Field of Scientific and Technical Research (COST), Germany, Gerodontology, Headache, International Collaborations, Joint and Back Pain, Kings College London, Leiden University Medical Center, London, MOBID Pain Scale, Mobilization-Observation-Behaviour-Intensity-Dementia (MOBID) Pain Scale, Netherlands, Non-Profit Collaborations, Norway, Norway Stavanger University Hospital, Otto-Friedrich University Bamberg, Pain Agitation and Behavioural Problems in People With Dementia in General Hospital Wards, Pain and Disruptive Behaviour, Pain Assessment in Impaired Cognition, Pain Assessment in Impaired Cognition (PAIC) Meta-Tool, Pain Assessment in Patients with Impaired Cognition Especially Dementia (COST Action TD1005), Pain Assessment Tools, Pain Control, Pain in Impaired Cognition: EU COST Programme (COST TD1005 Action), Pain Management, Pain Management in Older People with Dementia, Pain Medicine, Pain Prevalence, Pain-Indicative Behaviours, Physiological Psychology: Otto-Friedrich University Bamberg, Research Institute MOVE Amsterdam, Stavanger University Hospital, Toothache, Treatment of Pain to Reduce Behavioural Disturbances, Underlying Causes of BPSD, University of Amsterdam, University of Bamberg (Germany), University of Bergen, Untreated Pain, VU University Amsterdam, VU University Medical Center Amsterdam, Wolfson Centre for Age-Related Diseases: King’s College London
|
Leave a comment
